Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Financial Flexibility Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥116.82 Million (operating CF CN¥109.83 Million minus capex CN¥6.99 Million) represents 0% of total liabilities (CN¥676.78 Million). Check cash flow reinvestment rate of Shanghai Shenqi Pharmaceutical Investmen to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. For the full cash flow conversion analysis, see 600613 operating cash flow.
Annual Financial Flexibility Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. Explore Shanghai Shenqi Pharmaceutical Investmen (600613) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥157.69 Million | CN¥124.47 Million | CN¥747.59 Million | ▼ -40.5% |
| 2024 | 0.35x | CN¥244.18 Million | CN¥207.79 Million | CN¥689.01 Million | ▲ +31.2% |
| 2023 | 0.27x | CN¥240.10 Million | CN¥215.59 Million | CN¥888.77 Million | ▼ -21.3% |
| 2022 | 0.34x | CN¥345.87 Million | CN¥319.23 Million | CN¥1.01 Billion | ▼ -3.9% |
| 2021 | 0.36x | CN¥270.23 Million | CN¥184.26 Million | CN¥756.45 Million | ▲ +40.8% |
| 2020 | 0.25x | CN¥195.40 Million | CN¥99.10 Million | CN¥770.28 Million | ▲ +10.6% |
| 2019 | 0.23x | CN¥205.24 Million | CN¥128.28 Million | CN¥894.60 Million | ▼ -53.2% |
| 2018 | 0.49x | CN¥258.77 Million | CN¥148.53 Million | CN¥527.74 Million | ▲ +57.7% |
| 2017 | 0.31x | CN¥175.83 Million | CN¥66.99 Million | CN¥565.34 Million | ▲ +306.3% |
| 2016 | 0.08x | CN¥43.44 Million | CN¥570.41K | CN¥567.56 Million | ▼ -69.4% |
| 2015 | 0.25x | CN¥96.30 Million | CN¥30.12 Million | CN¥384.98 Million | ▲ +23.5% |
| 2014 | 0.20x | CN¥51.75 Million | CN¥-8.62 Million | CN¥255.60 Million | ▼ -71.5% |
| 2013 | 0.71x | CN¥130.33 Million | CN¥74.75 Million | CN¥183.42 Million | ▲ +270.2% |
| 2012 | -0.42x | CN¥-10.15 Million | CN¥-11.18 Million | CN¥24.31 Million | ▼ -1014.9% |
| 2011 | -0.04x | CN¥-1.18 Million | CN¥-3.33 Million | CN¥31.57 Million | ▼ -103.2% |
| 2010 | 1.18x | CN¥33.61 Million | CN¥33.04 Million | CN¥28.48 Million | ▲ +731.8% |
| 2009 | 0.14x | CN¥8.60 Million | CN¥7.69 Million | CN¥60.61 Million | ▼ -70.6% |
| 2008 | 0.48x | CN¥25.62 Million | CN¥25.26 Million | CN¥53.04 Million | ▲ +157.6% |
| 2007 | 0.19x | CN¥16.91 Million | CN¥16.01 Million | CN¥90.23 Million | ▲ +503.9% |
| 2006 | -0.05x | CN¥-4.88 Million | CN¥-6.05 Million | CN¥105.19 Million | ▼ -114.1% |
| 2005 | 0.33x | CN¥36.22 Million | CN¥32.72 Million | CN¥109.67 Million | ▲ +443.1% |
| 2004 | 0.06x | CN¥11.25 Million | CN¥4.96 Million | CN¥184.98 Million | ▲ +65.4% |
| 2003 | 0.04x | CN¥5.15 Million | CN¥4.52 Million | CN¥139.96 Million | ▼ -72.6% |
| 2002 | 0.13x | CN¥19.26 Million | CN¥16.02 Million | CN¥143.38 Million | ▲ +217.9% |
| 2001 | -0.11x | CN¥-17.91 Million | CN¥-20.51 Million | CN¥157.14 Million | ▼ -149.9% |
| 2000 | 0.23x | CN¥38.61 Million | CN¥26.85 Million | CN¥168.97 Million | ▲ +4.0% |
| 1999 | 0.22x | CN¥32.83 Million | CN¥-3.28 Million | CN¥149.46 Million | ▲ +14.1% |
| 1998 | 0.19x | CN¥74.01 Million | CN¥72.67 Million | CN¥384.28 Million | — |